North America

WeInfuse and Clarion Partner to Bring AI Agents to the Infusion and Pharmacy Front Office

Clarion's AI agents connect directly to WeInfuse to resolve routine patient calls using live order, authorization, and appointment data...

SQ Innovation’s Lasix ONYU Trial Shows Potential for At-Home Heart Failure Treatment

SUBCUT HF II is a multicenter, open-label, randomized controlled investigator-sponsored clinical trial that compared at-home treatment ...

Vantis Vascular Receives FDA Clearance for 6F CrossFAST Model

New 6 French model accommodates a broader range of devices while maintaining the integrated design and deliverability of CrossFAST...

AcuityMD Launches AI Research Agent for Faster MedTech Market Analysis

The agent runs multi-step analyses scoped to a company’s market, cited at every step, and re-runnable as new data arrives...

Blue Purpose Founder Don Glidewell Secures Third US Patent for BOOMBOX Emergency Communications Technology

The milestone reflects more than two decades of Glidewell's work at the intersection of healthcare, technology and emergency preparedness...

LUX Infusion Expands Access to Hemophilia Care with Qfitlia

LUX Infusion is currently authorized to dispense Qfitlia, expanding access to a unique bleeding disorder treatment option...

Wellysis Secures FDA Clearance for AI-Powered ECG Analysis Software, S-Patch CardioAI

Adds FDA-cleared AI analysis to Wellysis' S-Patch ECG monitoring solution, expanding its capabilities beyond ECG acquisition...

Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USP

The U.S. FDA has approved Lupin's Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-dose Prefilled Syringe as bioequivalent to the reference listed drug (RLD)...

ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Alzheimer's Disease Biomarker Research

Expanded Broadens Use of ALZpath's Proprietary pTau217 Antibody Technology across the Quanterix Simoa Research Portfolio...